Non-aspirin NSAIDs only one of many heart risks

cholesterol: heart on ecg graph
A renewed US Food and Drug Administration warning on non-aspirin NSAIDs and cardiovascular health is in line with current TGA recommendations – and community pharmacy can help educate consumers about the issue, a spokesperson for the Heart Foundation says. The FDA is strengthening an existing label warning that non-aspirin NSAIDs increase the chance of a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Consumers trust big brands and pharmacists: survey
Next Patients hurt by Medicare rebate freeze: AMA